Sol-Gel Technologies (SLGL) Competitors $42.90 +8.10 (+23.28%) Closing price 04:00 PM EasternExtended Trading$39.42 -3.48 (-8.11%) As of 06:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLGL vs. CHEK, DRCT, REPL, CGC, ALEC, MREO, UPXI, CADL, ALDX, and SCPHShould you be buying Sol-Gel Technologies stock or one of its competitors? The main competitors of Sol-Gel Technologies include Check-Cap (CHEK), Direct Digital (DRCT), Replimune Group (REPL), Canopy Growth (CGC), Alector (ALEC), Mereo BioPharma Group (MREO), Upexi (UPXI), Candel Therapeutics (CADL), Aldeyra Therapeutics (ALDX), and scPharmaceuticals (SCPH). Sol-Gel Technologies vs. Its Competitors Check-Cap Direct Digital Replimune Group Canopy Growth Alector Mereo BioPharma Group Upexi Candel Therapeutics Aldeyra Therapeutics scPharmaceuticals Sol-Gel Technologies (NASDAQ:SLGL) and Check-Cap (NASDAQ:CHEK) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, earnings and media sentiment. Does the media refer more to SLGL or CHEK? In the previous week, Check-Cap had 1 more articles in the media than Sol-Gel Technologies. MarketBeat recorded 1 mentions for Check-Cap and 0 mentions for Sol-Gel Technologies. Sol-Gel Technologies' average media sentiment score of 0.00 beat Check-Cap's score of -1.00 indicating that Sol-Gel Technologies is being referred to more favorably in the media. Company Overall Sentiment Sol-Gel Technologies Neutral Check-Cap Negative Do insiders & institutionals have more ownership in SLGL or CHEK? 26.2% of Sol-Gel Technologies shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 66.5% of Sol-Gel Technologies shares are held by company insiders. Comparatively, 0.5% of Check-Cap shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts recommend SLGL or CHEK? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sol-Gel Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is SLGL or CHEK more profitable? Check-Cap has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -14.25%. Check-Cap's return on equity of 0.00% beat Sol-Gel Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Sol-Gel Technologies-14.25% -11.80% -9.39% Check-Cap N/A N/A N/A Which has more volatility and risk, SLGL or CHEK? Sol-Gel Technologies has a beta of 1.29, meaning that its share price is 29% more volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Which has stronger earnings and valuation, SLGL or CHEK? Sol-Gel Technologies has higher revenue and earnings than Check-Cap. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSol-Gel Technologies$23.93M4.99-$10.58M-$1.23-34.88Check-CapN/AN/A-$25.15M-$3.00-0.70 SummarySol-Gel Technologies beats Check-Cap on 8 of the 13 factors compared between the two stocks. Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SLGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLGL vs. The Competition Export to ExcelMetricSol-Gel TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$96.95M$4.46B$6.16B$10.57BDividend YieldN/A0.90%5.50%4.66%P/E Ratio-34.8810.9285.5827.12Price / Sales4.9920.20612.74135.85Price / CashN/A7.4926.3031.10Price / Book4.144.0512.876.67Net Income-$10.58M-$134.23M$3.30B$276.23M7 Day Performance49.26%9.41%4.80%3.31%1 Month Performance53.43%8.31%8.11%10.76%1 Year Performance550.00%68.25%75.85%33.58% Sol-Gel Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLGLSol-Gel Technologies0.3299 of 5 stars$42.90+23.3%N/A+427.3%$96.95M$23.93M-34.8850High Trading VolumeCHEKCheck-Cap0.0531 of 5 stars$2.34+5.9%N/A+58.7%$12.93MN/A-0.7880DRCTDirect Digital3.4671 of 5 stars$0.31-5.7%$6.00+1,805.4%-85.8%$7.52M$36.46M-0.1760Positive NewsGap UpHigh Trading VolumeREPLReplimune Group4.7403 of 5 stars$4.34+5.1%$6.50+49.8%-59.1%$322.37MN/A-1.34210CGCCanopy Growth0.8528 of 5 stars$1.57+17.2%N/A-69.0%$321.40M$225.65M-0.523,150High Trading VolumeALECAlector3.7611 of 5 stars$3.05-1.6%$4.17+36.6%-28.1%$313.76M$100.56M-2.63270Analyst RevisionMREOMereo BioPharma Group2.4211 of 5 stars$1.96+1.0%$7.40+277.6%-53.6%$308.46M$10M-28.0040News CoveragePositive NewsUPXIUpexi2.5204 of 5 stars$5.62+7.7%$15.50+175.8%+217.9%$307.11M$15.81M0.00130Short Interest ↑CADLCandel Therapeutics2.4254 of 5 stars$5.40-2.5%$20.00+270.4%-16.4%$304.12MN/A-7.8360ALDXAldeyra Therapeutics2.3052 of 5 stars$5.21+2.8%$9.50+82.3%+7.5%$303.67MN/A-6.1310SCPHscPharmaceuticals3.8352 of 5 stars$5.67+0.4%$7.78+37.3%+32.5%$301.14M$36.33M-3.1330 Related Companies and Tools Related Companies Check-Cap Alternatives Direct Digital Alternatives Replimune Group Alternatives Canopy Growth Alternatives Alector Alternatives Mereo BioPharma Group Alternatives Upexi Alternatives Candel Therapeutics Alternatives Aldeyra Therapeutics Alternatives scPharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLGL) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredIs This Warren’s Buffett’s #1 AI Investment?Did you know that Warren Buffett is investing in what Jeff Brown believes will be the next generation of artif...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sol-Gel Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
